Three Companies Commit $1.7 Billion to BNB Treasury Strategies
Liminatus Pharma and CEA Industries have announced corporate treasury strategies involving BNB, totaling over $1 billion. This follows Windtree Therapeutics' $700 million BNB investment last week.
- Liminatus Pharma plans to create an "American BNB Strategy" subsidiary with a $500 million allocation in BNB as a long-term asset.
- CEA Industries disclosed a $500 million private placement to support its BNB investment.
- Binance founder Changpeng Zhao noted this is the third corporate BNB investment within a week.
- Windtree Therapeutics' investment has contributed to BNB reaching an all-time high of $858, with a market capitalization exceeding $120 billion.
Exchange Token Market Growth
BNB's rise has increased interest in exchange tokens, with total market capitalization hitting $161 billion. Uniswap's UNI token saw a 13.5% rise, while Bitget's BGB token increased by 12% during this period.
At press time, BNB is trading around $838, maintaining a 2.4% increase for the day. The token is expected to continue gaining momentum following recent institutional adoptions.